Protinhi develops virus inhibitor against Covid-19 – and its successors
Nijmegen-based biotech company is dependent on capital from venture investors and receives little extra money from the government for Corona research
Nijmegen-based biotech company is dependent on capital from venture investors and receives little extra money from the government for Corona research